The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial

[1] Filippi M(2018)Multiple sclerosis Nat Reviews Disease Primers 4 1-27

[2] Bar-Or A(2020)Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS Multiple Scler J 26 1816-21

[3] Piehl F(2013)Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis Multiple Scler Int 2013 319201-86

[4] Preziosa P(2022)Gastrointestinal motility disorders in patients with multiple sclerosis: a single-center study Neurogastroenterology & Motility 34 e14326-51

[5] Solari A(2022)The patient and clinician assessment of gastrointestinal (GI) related adverse events associated with oral disease-modifying therapies in multiple sclerosis: a qualitative study Adv Therapy 39 5072-42

[6] Vukusic S(1965)Prognostic criteria in multiple sclerosis Ann N Y Acad Sci 122 542-11

[7] Walton C(2020)Ginger on human health: a comprehensive systematic review of 109 randomized controlled trials Nutrients 12 157-98

[8] King R(2021)A recent update on the multifaceted health benefits associated with ginger and its bioactive components Food Funct 12 519-9

[9] Rechtman L(2023)The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial Food Funct 14 3701-108

[10] Kaye W(2017)Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: a review Ann N Y Acad Sci 1398 83-55

[1] Filippi M(2018)Multiple sclerosis Nat Reviews Disease Primers 4 1-27

[2] Bar-Or A(2020)Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS Multiple Scler J 26 1816-21

[3] Piehl F(2013)Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis Multiple Scler Int 2013 319201-86

[4] Preziosa P(2022)Gastrointestinal motility disorders in patients with multiple sclerosis: a single-center study Neurogastroenterology & Motility 34 e14326-51

[5] Solari A(2022)The patient and clinician assessment of gastrointestinal (GI) related adverse events associated with oral disease-modifying therapies in multiple sclerosis: a qualitative study Adv Therapy 39 5072-42

[6] Vukusic S(1965)Prognostic criteria in multiple sclerosis Ann N Y Acad Sci 122 542-11

[7] Walton C(2020)Ginger on human health: a comprehensive systematic review of 109 randomized controlled trials Nutrients 12 157-98

[8] King R(2021)A recent update on the multifaceted health benefits associated with ginger and its bioactive components Food Funct 12 519-9

[9] Rechtman L(2023)The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial Food Funct 14 3701-108

[10] Kaye W(2017)Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: a review Ann N Y Acad Sci 1398 83-55